Certuity’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
3,309
+139
| +4% | +$61.9K | 0.14% | 101 |
|
|
2025
Q1 | $1.54M | Sell |
3,170
-132
| -4% | -$64K | 0.16% | 90 |
|
|
2024
Q4 | $1.33M | Sell |
3,302
-480
| -13% | -$193K | 0.14% | 96 |
|
|
2024
Q3 | $1.76M | Sell |
3,782
-737
| -16% | -$343K | 0.19% | 93 |
|
|
2024
Q2 | $2.12M | Buy |
4,519
+431
| +11% | +$202K | 0.17% | 73 |
|
|
2024
Q1 | $1.71M | Buy |
4,088
+1,508
| +58% | +$630K | 0.15% | 78 |
|
|
2023
Q4 | $1.05M | Buy |
2,580
+433
| +20% | +$176K | 0.11% | 103 |
|
|
2023
Q3 | $747K | Buy |
2,147
+339
| +19% | +$118K | 0.09% | 97 |
|
|
2023
Q2 | $636K | Buy |
1,808
+821
| +83% | +$289K | 0.07% | 121 |
|
|
2023
Q1 | $311K | Buy |
987
+141
| +17% | +$44.4K | 0.05% | 154 |
|
|
2022
Q4 | $244K | Sell |
846
-2,697
| -76% | -$779K | 0.04% | 178 |
|
|
2022
Q3 | $1.03M | Buy |
3,543
+2,754
| +349% | +$798K | 0.24% | 50 |
|
|
2022
Q2 | $222K | Buy |
+789
| New | +$222K | 0.06% | 191 |
|
|
2021
Q4 | – | Sell |
-1,119
| Closed | -$204K | – | 396 |
|
|
2021
Q3 | $204K | Sell |
1,119
-36
| -3% | -$6.56K | 0.04% | 360 |
|
|
2021
Q2 | $233K | Sell |
1,155
-23
| -2% | -$4.64K | 0.05% | 282 |
|
|
2021
Q1 | $253K | Buy |
1,178
+188
| +19% | +$40.4K | 0.07% | 235 |
|
|
2020
Q4 | $234K | Buy |
+990
| New | +$234K | 0.08% | 190 |
|
|
2020
Q2 | – | Sell |
-1,446
| Closed | -$338K | – | 188 |
|
|
2020
Q1 | $338K | Sell |
1,446
-31
| -2% | -$7.25K | 0.19% | 83 |
|
|
2019
Q4 | $323K | Buy |
+1,477
| New | +$323K | 0.15% | 111 |
|